Who
Todd S. Young
Chief Financial Officer
Company insider
Files Form 4 as: Chief Financial Officer, Acadia Healthcare Company; Officer, Elanco Animal Health; EVP and CFO, ACADIA Pharmaceuticals.
In numbers
- Trades disclosed
- 67
- Buys
- 2
- Sells
- 0
- Bought
- $433K
- Sold
- $0
- Companies
- 3
- Companies where not an officer
- 0
- First trade
- 22 Aug 2016
- Last trade
- 10 Apr 2026
- Last filed
- 13 Apr 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Apr 2026filed 13 Apr 2026 | ACHC Acadia Healthcare CompanyProviders & Facilities | SEC FORM 4 Code A | —58,799 at $0.00 | filing |
| 10 Apr 2026filed 13 Apr 2026 | ACHC Acadia Healthcare CompanyProviders & Facilities | SEC FORM 4 Code A | —58,799 at $0.00 | filing |
| 27 Oct 2025filed 28 Oct 2025 | ACHC Acadia Healthcare CompanyProviders & Facilities | SEC FORM 4 Code A | —48,445 at $0.00 | filing |
| 4 Mar 2025filed 4 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —4,000 at $0.00 | filing |
| 4 Mar 2025filed 4 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —4,000 at $0.00 | filing |
| 4 Mar 2025filed 4 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —2,000 at $0.00 | filing |
| 4 Mar 2025filed 4 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —2,000 at $0.00 | filing |
| 4 Mar 2025filed 4 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —2,000 at $0.00 | filing |
| 4 Mar 2025filed 4 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —2,000 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | ELAN Elanco Animal Healthoption or derivative · Pharmaceuticals | SEC FORM 4 Code A | —134,509 at $0.00 | filing |
| 3 Mar 2025filed 5 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —64,103 at $0.00 | filing |
| 1 Mar 2025filed 4 Mar 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code F | $203K18,196 at $11.17 | filing |
| 19 Feb 2025filed 21 Feb 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code A | —104,930 at $0.00 | filing |
| 19 Feb 2025filed 21 Feb 2025 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code F | $518K46,045 at $11.24 | filing |
| 5 Mar 2024filed 5 Mar 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —37,999 at $0.00 | filing |
| 5 Mar 2024filed 5 Mar 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —37,999 at $0.00 | filing |
| 5 Mar 2024filed 5 Mar 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —1,500 at $0.00 | filing |
| 5 Mar 2024filed 5 Mar 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —1,500 at $0.00 | filing |
| 5 Mar 2024filed 5 Mar 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —1,500 at $0.00 | filing |
| 5 Mar 2024filed 5 Mar 2024 | ELAN Elanco Animal HealthPharmaceuticals | SEC FORM 4 Code G | —1,500 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.